Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Zopiclone

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 825Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Taiwan bans four types of sleeping pills for certain patients
    Taiwan bans four types of sleeping pills for certain patients

    28 Apr 2020

    // Sophia Yang TAIWANNEWS

    https://www.taiwannews.com.tw/en/news/3924427

    Sophia Yang TAIWANNEWS
    28 Apr 2020
    Share Share
    Eisai, Purdue reveal eye-opening data for sleep drug
    Eisai, Purdue reveal eye-opening data for sleep drug

    06 Jun 2018

    // Phil Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/eisai-purdue-reveal-eye-opening-data-for-sleep-drug-lemborexant

    Phil Taylor FIERCE BIOTECH
    06 Jun 2018
    Share Share
    Research and Markets: China Sleep Disorder Treatment Drugs Markets Report 2015
    Research and Markets: China Sleep Disorder Treatment Drugs Markets Report 2015

    21 Jan 2015

    // BUSINESS WIRE

    http://www.businesswire.com/news/home/20150121005725/en/Research-Markets-China-Sleep-Disorder-Treatment-Drugs#.VMCL8NKUde8

    BUSINESS WIRE
    21 Jan 2015
    Share Share